Drug May Repair DNA at Earliest Stages of Alzheimer’s – And it’s Already Passed Safety Trials
(www.goodnewsnetwork.org)
https://pmc.ncbi.nlm.nih.gov/articles/PMC10835503/
Safety testing on humans (P1) is complete. No efficacy measures in the study, but that's not out of the norm for P1.